The RNA-activated protein kinase enhances the induction of interferon-beta and apoptosis mediated by cytoplasmic RNA sensors.
Detection of foreign RNA by the innate immune system can trigger the induction of type I interferon (IFN) and apoptosis. Important antiviral defense pathways that result in type I IFN production following the recognition of foreign double-stranded RNA (dsRNA) include the RIG-I family helicases and IPS-1 adaptor cytosolic pathway and the Toll-like receptor 3 and TIR domain-containing adaptor-inducing IFN-beta (TRIF) adaptor membrane-associated pathway, both of which activate IFN regulatory factor 3 (IRF3). In addition to triggering an innate immune response, dsRNAs are widely used to mediate gene-selective silencing in mammalian cells by the RNA interference pathway. We investigated the ability of short interfering RNAs, including T7 phage polymerase-synthesized RNA (PRNA), which like some viral RNAs contains a 5'-triphosphate, to selectively silence gene expression and to cause induction of IFN-beta and apoptosis. We found that PRNA-mediated gene silencing and associated nonspecific pro-apoptotic and IFN-inducing effects were dependent on the cell line and RNA length. Double-stranded PRNAs 50 nucleotides long as well as polyinosinic-polycytidylic acid activated the RNA-dependent protein kinase (PKR) and induced significant levels of IFN-beta and apoptosis, whereas shorter PRNAs and chemically synthesized dsRNAs did not. Effector caspase activation and apoptosis following RNA transfection was enhanced by pretreatment with IFN, and removal of the 5'-phosphate from PRNAs decreased induction of both IFN-beta and apoptosis. PKR, in addition to IPS-1 and IRF3 but not TRIF, was required for maximal type I IFN-beta induction and the induction of apoptosis by both transfected PRNAs and polyinosinic-polycytidylic acid.
McAllister
Christopher S
CS
Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, California 93106, USA.
Samuel
Charles E
CE
D048868:Adaptor Proteins, Signal Transducing / Q000276:immunology / Q000378:metabolism*; D033942:Adaptor Proteins, Vesicular Transport / Q000276:immunology / Q000378:metabolism; D000818:Animals; D017209:Apoptosis / Q000276:immunology / Q000502:physiology*; D016466:CHO Cells; D020169:Caspases / Q000276:immunology / Q000378:metabolism; D006224:Cricetinae; D003412:Cricetulus; D020868:Gene Silencing; D006367:HeLa Cells; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects / Q000502:physiology; D050838:Interferon Regulatory Factor-3 / Q000276:immunology / Q000378:metabolism*; D016899:Interferon-beta / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D011070:Poly I-C / Q000276:immunology / Q000378:metabolism / Q000494:pharmacology; D012330:RNA, Double-Stranded / Q000276:immunology / Q000378:metabolism* / Q000494:pharmacology; D051196:Toll-Like Receptor 3 / Q000276:immunology / Q000378:metabolism; D019892:eIF-2 Kinase / Q000276:immunology / Q000378:metabolism*
D048868:Adaptor Proteins, Signal Transducing; D033942:Adaptor Proteins, Vesicular Transport; D020169:Caspases; D050838:Interferon Regulatory Factor-3; D016899:Interferon-beta; D011070:Poly I-C; D012330:RNA, Double-Stranded; D051196:Toll-Like Receptor 3; D019892:eIF-2 Kinase; C512612:MAVS protein, mouse; C494232:IRF3 protein, human; C494233:Irf3 protein, mouse; C505371:MAVS protein, human; C476286:Ticam1 protein, mouse; C470409:TICAM1 protein, human; C495344:TLR3 protein, human; C519703:TLR3 protein, mouse